Domingues Rita, Barbosa Ana, Santos Sílvio B, Pires Diana Priscila, Save Jonathan, Resch Grégory, Azeredo Joana, Oliveira Hugo
Centre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal.
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland.
Antibiotics (Basel). 2021 Oct 26;10(11):1304. doi: 10.3390/antibiotics10111304.
is a species that belong to the complex, increasingly recognized as major nosocomial bacterial pathogens, often associated with multiple drug-resistances. The capsule surrounding the bacteria represents a main virulence factor, helping cells avoid phage predation and host immunity. Accordingly, a better understanding of the phage infection mechanisms is required to efficiently develop phage therapy against of different capsular types. Here, we report the isolation of the novel -infecting Fri1-like phage vB_Api_3043-K38 (3043-K38) of the morphotype, from sewage samples. Its 41,580 bp linear double-stranded DNA genome harbours 53 open reading frames and 302 bp of terminal repeats. We show that all studied Fri1-like viruses have highly similar genomes, which differentiate only at the genes coding for tailspike, likely to adapt to different host receptors. The isolated phage 3043-K38 specifically recognizes an untapped K38 capsule type via a novel tailspike with K38 depolymerase activity. The recombinant K38 depolymerase region of the tailspike (center-end region) forms a thermostable trimer, and quickly degrades capsules. When the K38 depolymerase is applied to the cells, it makes them resistant to phage predation. Interestingly, while K38 depolymerase treatments do not synergize with antibiotics, it makes bacterial cells highly susceptible to the host serum complement. In summary, we characterized a novel phage-encoded K38 depolymerase, which not only advances our understanding of phage-host interactions, but could also be further explored as a new antibacterial agent against drug-resistant .
是属于该复合体的一个物种,越来越被认为是主要的医院细菌病原体,常与多重耐药性相关。细菌周围的荚膜是主要的毒力因子,有助于细胞避免噬菌体捕食和宿主免疫。因此,需要更好地了解噬菌体感染机制,以有效地开发针对不同荚膜类型的噬菌体疗法。在这里,我们报告从污水样本中分离出了一种新型的感染的形态型Fri1样噬菌体vB_Api_3043-K38(3043-K38)。其41,580 bp的线性双链DNA基因组包含53个开放阅读框和302 bp的末端重复序列。我们表明,所有研究的Fri1样病毒都有高度相似的基因组,仅在编码尾刺的基因上有所不同,可能是为了适应不同的宿主受体。分离出的噬菌体3043-K38通过具有K38解聚酶活性的新型尾刺特异性识别未被利用的K38荚膜类型。尾刺的重组K38解聚酶区域(中心-末端区域)形成一个热稳定的三聚体,并能快速降解荚膜。当将K38解聚酶应用于细胞时,它会使细胞对噬菌体捕食具有抗性。有趣的是,虽然K38解聚酶处理与抗生素没有协同作用,但它会使细菌细胞对宿主血清补体高度敏感。总之,我们鉴定了一种新型的噬菌体编码的K38解聚酶,它不仅增进了我们对噬菌体-宿主相互作用的理解,还可以作为一种针对耐药的新型抗菌剂进行进一步探索。